AXSOME THERAPEUTICS INC's ticker is and the CUSIP is 05464T954. A total of 3 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $887 | -76.2% | 12,700 | -75.5% | 0.00% | -66.7% |
| Q2 2023 | $3,722 | -17.4% | 51,800 | -29.1% | 0.00% | -25.0% |
| Q1 2023 | $4,508 | -39.8% | 73,100 | -24.7% | 0.00% | -50.0% |
| Q4 2022 | $7,489 | -99.9% | 97,100 | -14.7% | 0.01% | +33.3% |
| Q3 2022 | $5,077,000 | -36.2% | 113,800 | -45.2% | 0.01% | -25.0% |
| Q2 2022 | $7,954,000 | +223.1% | 207,700 | +249.1% | 0.01% | +300.0% |
| Q1 2022 | $2,462,000 | +268.6% | 59,500 | +236.2% | 0.00% | +100.0% |
| Q4 2021 | $668,000 | +554.9% | 17,700 | +1080.0% | 0.00% | – |
| Q3 2021 | $102,000 | +1.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $101,000 | -40.2% | 1,500 | +4900.0% | 0.00% | – |
| Q1 2021 | $169,000 | – | 30 | -91.3% | 0.00% | – |
| Q4 2020 | $0 | – | 345 | -50.2% | 0.00% | – |
| Q3 2020 | $0 | – | 693 | -16.1% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 826 | +13.6% | 0.00% | -100.0% |
| Q1 2020 | $4,276,000 | -58.7% | 727 | -27.4% | 0.01% | -65.2% |
| Q4 2019 | $10,356,000 | +1269.8% | 1,002 | +167.9% | 0.02% | +1050.0% |
| Q3 2019 | $756,000 | -17.7% | 374 | +4.8% | 0.00% | -33.3% |
| Q2 2019 | $919,000 | -39.1% | 357 | -66.3% | 0.00% | -25.0% |
| Q1 2019 | $1,508,000 | +150700.0% | 1,060 | +26400.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 4 | +300.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 117,400 | $6,647,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 30 | $169,000 | 0.00% |